This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Xpovio

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Xpovio Means in Everyday Medical Language

Xpovio is the brand name for the drug selinexor, a medicine used to treat certain cancers such as some types of lymphoma and multiple myeloma. It works by blocking a protein called CRM1 (also known as exportin 1), which cancer cells use to grow and survive. By stopping this protein, selinexor can slow down or kill cancer cells. This drug belongs to a group called selective inhibitors of nuclear export, which is a newer type of targeted cancer therapy.

Why Xpovio Can Matter in Cancer Care

Selinexor is often used when other cancer treatments have not worked or when the cancer has returned after previous therapies. For example, it is approved for adults with diffuse large B-cell lymphoma who have tried at least two other treatments, and for multiple myeloma patients who have received several prior therapies. Because it works differently from many other cancer drugs, it may help when other medicines no longer do. This makes it an important option for people whose cancers are resistant to standard treatments.

What Patients Might See, Feel, or Be Told

If your doctor mentions selinexor or Xpovio, you might take it as a pill, often combined with other drugs like dexamethasone or bortezomib. Common side effects include feeling tired, nausea, vomiting, loss of appetite, diarrhea, and low blood counts such as low platelets or anemia. These side effects can sometimes be managed with supportive care or dose changes. Your care team will monitor you closely during treatment to help manage these effects.

Where You Might Encounter the Term Xpovio

You may see selinexor or Xpovio mentioned in your medical records, treatment plans, lab reports, or drug information pages. It can also appear on clinical trial listings or patient education materials. Because it has several names, including its research code KPT-330, comparing these names can help avoid confusion. If you find the term in any document, it’s important to ask your healthcare provider what it means for your care specifically.

What Xpovio Does Not Automatically Mean

Seeing the name selinexor or Xpovio does not mean you have a certain diagnosis or that this drug is the right treatment for you. It is one option among many and is usually used after other treatments have been tried. It also does not guarantee a cure or specific results. Each person’s situation is unique, so the presence of this drug in your care plan should be discussed with your medical team to understand its role.

Common Questions to Ask Your Care Team

You might want to ask how selinexor works for your type of cancer, what side effects to expect, and how they will be managed. It’s also helpful to ask about how this drug fits with other treatments you have had or may receive. If you see the term in a report or plan, ask what it means for your current care and what to watch for during treatment.

How to Read the Term in Context

When you see selinexor or Xpovio mentioned, remember it is part of a larger treatment plan. It is important not to focus on the drug name alone but to understand how it fits your specific diagnosis, treatment goals, and health status. Always discuss with your healthcare team to get clear, personalized information.

Safety and Next Steps

This information is meant to help you understand what selinexor is and how it might be used in cancer treatment. It is not a recommendation or a complete guide to your care. Always rely on your healthcare team for advice tailored to your health. If you have questions or concerns about selinexor or your treatment, the best next step is to talk openly with your doctors and nurses to get answers that fit your situation.

Sources

Public source information used for this glossary entry includes: